Found 6 results
Author Title [ Type(Desc)] Year
Filters: Author is Sen, HN  [Clear All Filters]
Journal Article
R. R. Buggage, Levy-Clarke, G., Sen, H. N., Ursea, R., Srivastava, S. K., Suhler, E. B., Alternare, C., Velez, G., Ragheb, J., Chan, C., Nussenblatt, R. B., Bamji, A. T., Sran, P., Waldmann, T., and Thompson, D., A Double-Masked, Randomized Study to Investigate the Safety and Efficacy of Daclizumab to Treat the Ocular Complications Related to Behçet's Disease, Ocul Immunol Inflamm, vol. 15, pp. 63-70, 2007.
R. B. Nussenblatt, Thompson, D. J. S., Li, Z., Peterson, J. S., Robinson, R. R., Shames, R. S., Nagarajan, S., Tang, M. T., Mailman, M., Velez, G., Roy, C., Levy-Clarke, G. A., Suhler, E. B., Djalilian, A., Sen, H. N., Al-Khatib, S., Ursea, R., Srivastava, S., Bamji, A., Mellow, S., Sran, P., and , Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration, J Autoimmun, vol. 21, pp. 283-293, 2003.
H. N. Sen, Sangave, A., Hammel, K., Levy-Clarke, G., and Nussenblatt, R. B., Infliximab for the Treatment of Active Scleritis, Can J Ophthalmol, vol. 44, pp. e9-e12, 2009.
H. N. Sen, Buggage, R., Hammel, K., Levy-Clarke, G., and Nussenblatt, R., Infliximab for the Treatment of Scleritis and Recalcitrant Uveitis, 2008.
R. B. Nussenblatt, Rao, N. A., Foster, C. S., Sen, H. N., Srivastava, S., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Robinson, R. R., Shames, R. S., and Buggage, R. R., Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis, 2003.
R. B. Nussenblatt, Rao, N., Foster, C. S., Sen, H. N., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Shames, R. S., and Buggage, R. R., Uveitis therapy: a phase II study using subcutaneously administered daclizumab, 2004.